Journal article
Management of Cardiovascular Health in People with Severe Mental Disorders
Current cardiology reports, Vol.23(2), pp.7-7
01/06/2021
DOI: 10.1007/s11886-020-01436-5
PMID: 33409804
Abstract
To review evidence regarding the association between bipolar disorder and schizophrenia, henceforth referred to as severe mental disorders (SMD), and cardiovascular morbidity and mortality, its mechanisms, and the interventions to reduce this burden.
Much of the loss in life expectancy in people with SMD remains driven by cardiovascular mortality. Antipsychotics and mood stabilizers are associated with negative cardio-metabolic outcomes, but large inter-individual differences are observed, and not treating SMD might be associated with even greater cardiovascular mortality. Classical modifiable cardiovascular risk factors remained inadequately screened and, once identified, too seldom treated in people with SMD. After a myocardial infarction, aggressive tertiary prevention may be as effective in people with SMD as in the general population but is less prescribed. Reduced healthcare quality and increased prevalence of cardiovascular risk factors may not fully explain the excess cardiovascular mortality associated with SMDs, which themselves should be considered risk factors in risk calculators. Hazardous health behaviors, the cardio-metabolic adverse effects of medications, and a reduced access to quality healthcare remain priority targets for intervention.
Details
- Title: Subtitle
- Management of Cardiovascular Health in People with Severe Mental Disorders
- Creators
- Cédric Lemogne - Université de Paris, AP-HP, Hôpital Hôtel-Dieu, DMU Psychiatrie et Addictologie, Service de Psychiatrie de l'adulte, INSERM, Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, Paris, France. cedric.lemogne@aphp.frJacques Blacher - Université de Paris, AP-HP, Hôpital Hôtel-Dieu, Centre de Diagnostic et de Thérapeutique, Paris, FranceGuillaume Airagnes - Université de Paris, AP-HP, Hôpital européen Georges-Pompidou, DMU Psychiatrie et Addictologie, Centre Ambulatoire d'Addictologie, INSERM, UMS 011 Cohortes Epidémiologiques en Population, Paris, FranceNicolas Hoertel - Université de Paris, AP-HP, Hôpital Corentin-Celton, DMU Psychiatrie et Addictologie, Service de Psychiatrie de l'adulte et du sujet âgé, INSERM, Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, Issy-les-Moulineaux, FranceSébastien Czernichow - Université de Paris, AP-HP, Hôpital européen Georges-Pompidou, Service de Nutrition, Paris, FranceNicolas Danchin - Université de Paris, AP-HP, Hôpital européen Georges-Pompidou, Service de Cardiologie, Paris, FrancePierre Meneton - INSERM U1142 LIMICS, UMRS 1142, Sorbonne Universities, UPMC University of Paris 06, University of Paris 13, Paris, FranceFrédéric Limosin - Université de Paris, AP-HP, Hôpital Corentin-Celton, DMU Psychiatrie et Addictologie, Service de Psychiatrie de l'adulte et du sujet âgé, INSERM, Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, Issy-les-Moulineaux, FranceJess G Fiedorowicz - The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada
- Resource Type
- Journal article
- Publication Details
- Current cardiology reports, Vol.23(2), pp.7-7
- Publisher
- United States
- DOI
- 10.1007/s11886-020-01436-5
- PMID
- 33409804
- ISSN
- 1523-3782
- eISSN
- 1534-3170
- Language
- English
- Date published
- 01/06/2021
- Academic Unit
- Psychiatry; Epidemiology; Iowa Neuroscience Institute
- Record Identifier
- 9984070212502771
Metrics
17 Record Views